Publications search

Found 37769 matches. Displaying 2821-2830
Baker SK
Show All Authors

Plasminogen mediates communication between the peripheral and central

JOURNAL OF NEUROINFLAMMATION 2019 AUG 28; 16(1):? Article 172
Background Systemic inflammation has been implicated in the progression
Galea S, Vaughan R
Show All Authors

On Choosing the Right Starting Question: A Public Health of Consequence, August 2019

AMERICAN JOURNAL OF PUBLIC HEALTH 2019 AUG; 109(8):1075-1076
Li SQ
Show All Authors

Chaperoning RPA during DNA metabolism

CURRENT GENETICS 2019 AUG; 65(4):857-864
Single-stranded DNA (ssDNA) is widely generated during DNA metabolisms
McCabe M
Show All Authors

CE: Original Research: The Clinical Research Nurse: Exploring

AMERICAN JOURNAL OF NURSING 2019 AUG; 119(8):24-32
Background: Clinical research nursing is an emerging specialty practice.
Roco JA
Show All Authors

Class-Switch Recombination Occurs Infrequently in Germinal Centers

IMMUNITY 2019 AUG 20; 51(2):337-350.e7
Class-switch recombination (CSR) is a DNA recombination process that
Byrd AS
Show All Authors

Specimen Collection for Translational Studies in Hidradenitis

SCIENTIFIC REPORTS 2019 AUG 21; 9(?):? Article 12207
Hidradenitis suppurativa (HS) is a chronic inflammatory disorder
Raz A, Serrano A, Hernandez A, Euler CW, Fischetti VA
Show All Authors

Isolation of Phage Lysins That Effectively Kill Pseudomonas aeruginosa in Mouse Models of Lung and Skin Infection

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 2019 JUL; 63(7):? Article e00024-19
Multidrug resistance (MDR) is rapidly increasing in prevalence among isolates of the opportunistic pathogen Pseudomonas aeruginosa, leaving few treatment options. Phage lysins are cell wall hydrolases that have a demonstrated therapeutic potential against Gram-positive pathogens; however, the outer membrane of Gram-negative bacteria prevents most lysins from reaching the peptidoglycan, making them less effective as therapeutics. Nevertheless, a few lysins from Gram-negative bacterial phage can penetrate the bacterial outer membrane with the aid of an amphipathic tail found in the molecule's termini. In this work, we took a phylogenetic approach to systematically identify those lysins from P. aeruginosa phage that would be most effective therapeutically. We isolated and performed preliminary characterization of 16 lysins and chose 2 lysins, PlyPa03 and PlyPa91, which exhibited >5-log killing activity against P. aeruginosa and other Gram-negative pathogens (particularly Klebsiella and Enterobacter). These lysins showed rapid killing kinetics and were active in the presence of high concentrations of salt and urea and under pH conditions ranging from 5.0 to 10.0. Activity was not inhibited in the presence of the pulmonary surfactant beractant (Survanta). While neither enzyme was active in 100% human serum, PlyPa91 retained activity in low serum concentrations. The lysins were effective in the treatment of a P. aeruginosa skin infection in a mouse model, and PlyPa91 protected mice in a lung infection model, making these lysins potential drug candidates for Gram-negative bacterial infections of the skin or respiratory mucosa.
Queiroz-Telles F, Mercier T, Maertens J, Sola CBS, Bonfim C, Lortholary O, Constantino-Silva RMN, Schrijvers R, Hagen F, Meis JF, Herkert PF, Breda GL, Franca JB, Rosario NA, Lanternier F, Casanova JL, Puel A, Grumach AS
Show All Authors

Successful Allogenic Stem Cell Transplantation in Patients with Inherited CARD9 Deficiency

JOURNAL OF CLINICAL IMMUNOLOGY 2019 JUL; 39(5):462-469
Autosomal recessive (AR) CARD9 (caspase recruitment domain-containing protein 9) deficiency underlies invasive infections by fungi of the ascomycete phylum in previously healthy individuals at almost any age. Although CARD9 is expressed mostly by myeloid cells, the cellular basis of fungal infections in patients with inherited CARD9 deficiency is unclear. Therapy for fungal infections is challenging, with at least 20% premature mortality. We report two unrelated patients from Brazil and Morocco with AR CARD9 deficiency, both successfully treated with hematopoietic stem cell transplantation (HSCT). From childhood onward, the patients had invasive dermatophytic disease, which persisted or recurred despite multiple courses of antifungal treatment. Sanger sequencing identified homozygous missense CARD9 variants at the same residue, c.302G>T (p.R101L) in the Brazilian patient and c.301C>T (p.R101C) in the Moroccan patient. At the ages of 25 and 44 years, respectively, they received a HSCT. The first patient received a HLA-matched HSCT from his CARD9-mutated heterozygous sister. There was 100% donor chimerism at D+100. The other patient received a T cell-depleted haploidentical HSCT from his CARD9-mutated heterozygous brother. A second HSCT from the same donor was performed due to severe amegakaryocytic thrombocytopenia despite achieving full donor chimerism (100%). At last follow-up, more than 3 years after HSCT, both patients have achieved complete clinical remission and stopped antifungal therapy. HSCT might be a life-saving therapeutic option in patients with AR CARD9 deficiency. This observation strongly suggests that the pathogenesis of fungal infections in these patients is largely due to the disruption of leukocyte-mediated CARD9 immunity.
Perea-Gomez A
Show All Authors

Loss of Cubilin, the intrinsic factor-vitamin B12 receptor, impairs

SCIENTIFIC REPORTS 2019 JUL 15; 9(?):? Article 10168
The visceral endoderm is a polarized epithelial monolayer necessary for
Arazi A, Rao DA, Berthier CC, Davidson A, Liu YY, Hoover PJ, Chicoine A, Eisenhaure TM, Jonsson AH, Li SQ, Lieb DJ, Zhang F, Slowikowski K, Browne EP, Noma A, Sutherby D, Steelman S, Smilek DE, Tosta P, Apruzzese W, Massarotti E, Dall'Era M, Park M, Kamen DL, Furie RA, Payan-Schober F, Pendergraft WF, McInnis EA, Buyon JP, Petri MA, Putterman C, Kalunian KC, Woodle ES, Lederer JA, Hildeman DA, Nusbaum C, Raychaudhuri S, Kretzler M, Anolik JH, Brenner MB, Wofsy D, Hacohen N, Diamond B, Waguespack D, Connery SM, McMahon MA, McCune WJ, Kado RB, Hsu R, Cunningham MA, Utz PJ, Pichavant M, Maecker HT, Gupta R, James JA, Guthridge JM, Fonseka C, Der E, Clancy R, Tuschl T, Suryawanshi H, Fava A, Goldman DH
Show All Authors

The immune cell landscape in kidneys of patients with lupus nephritis

NATURE IMMUNOLOGY 2019 JUL; 20(7):902-927
Lupus nephritis is a potentially fatal autoimmune disease for which the current treatment is ineffective and often toxic. To develop mechanistic hypotheses of disease, we analyzed kidney samples from patients with lupus nephritis and from healthy control subjects using single-cell RNA sequencing. Our analysis revealed 21 subsets of leukocytes active in disease, including multiple populations of myeloid cells, Tcells, natural killer cells and B cells that demonstrated both pro-inflammatory responses and inflammation-resolving responses. We found evidence of local activation of B cells correlated with an age-associated B-cell signature and evidence of progressive stages of monocyte differentiation within the kidney. A clear interferon response was observed in most cells. Two chemokine receptors, CXCR4 and CX3CR1, were broadly expressed, implying a potentially central role in cell trafficking. Gene expression of immune cells in urine and kidney was highly correlated, which would suggest that urine might serve as a surrogate for kidney biopsies.